Clinical Trial Update: Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing immunogenicity, safety, and interchangeability of two tick-borne encephalitis vaccines given on a conventional schedule …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Drugs mentioned

• Pfizer vaccine (two TBE vaccines)

Snippet

Sponsor: Pfizer | Conditions: Encephalitis, Tick-Borne | Phase 3 | Status: COMPLETED | Results posted: 2024-01-19